Pfizer Inc. (0Q1N)
LSE
Closed
Oct 9, 2026
Day's Range
27.6052 wk Range
21.83Overview - 0Q1N - Pfizer Inc.
Key Statistics
Valuation
Enterprise Value
195.62B
P/E (Trailing)
‪6.27‬
PEG Ratio
‪-0.05‬
Price / Sales (TTM)
‪1.83‬
Price / Book
‪1.34‬
EV / EBITDA
‪6.29‬
Profitability
Gross Margin
‪72.78%‬
Profit Margin
‪27.55%‬
Operating Margin
‪32.52%‬
Return on Assets
‪7.62%‬
Return on Equity
‪23.06%‬
Ownership
Shares Outstanding
5.69B
Float
5.64B
Held by Insiders
‪0.04%‬
Held by Institutions
‪70.76%‬
Price stats
Beta
‪0.56‬
50-Day Avg
‪27.38‬
200-Day Avg
‪26.45‬
Dividends
Payout Ratio
‪43.09%‬
Frequency
Quarterly
Market Cap - 0Q1N - Pfizer Inc.
Peers - 0Q1N - Pfizer Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on LSE.
- 0Q1NLSEPfizer Inc.170.60BMarket Cap+1.96%52-week change6.27P/E (Trailing)‪27.55%‬Profit Margin
- AZNLSEAstraZeneca PLC18.97TMarket Cap+2.93%52-week change25.26P/E (Trailing)‪17.02%‬Profit Margin
- GSKLSEGSK plc7.41TMarket Cap+21.34%52-week change16.10P/E (Trailing)‪14.52%‬Profit Margin
- SANLSESantander UK Plc Preferred Stock 10.375% Perpetual4.72TMarket Cap+98.91%52-week change0.38P/E (Trailing)‪19.73%‬Profit Margin
- 0QIULSENovo Nordisk A/S1.06TMarket Cap-37.73%52-week change17.11P/E (Trailing)‪33.39%‬Profit Margin
- 0Q1GLSEEli Lilly and Company984.08BMarket Cap+26.67%52-week change1.49P/E (Trailing)‪33.52%‬Profit Margin
- 0QCVLSEAbbVie Inc.476.72BMarket Cap+16.79%52-week change54.53P/E (Trailing)‪15.50%‬Profit Margin
Profile Summary - 0Q1N - Pfizer Inc.
About
Pfizer Inc. is a global biopharmaceutical company that discovers, develops, manufactures, and markets medicines and vaccines for people worldwide. Its current portfolio spans oncology, vaccines, internal medicine, inflammation and immunology, rare diseases, and hospital-based care, supported by a broad commercial…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
